Abstract
THU599 - Efficacy and safety of Atezolizumab plus Bevacizumab-based sequential treatment for unresectable hepatocellular carcinoma: a simulation model
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have